Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological ...

The Nuclear Medicine Department at Ridley-Tree Cancer Center (now part of Sutter Health) has announced greater capabilities to treat prostate cancer using ...

OP-3136 showed activity that was independent of KAT6 amplification or over expression. In the OVCAR3 model, OP-3136 monotherapy demonstrated sustained tumor regression across the 28-day study period ...

The first patient has been enrolled in a trial evaluating ClarityDX Prostate’s impact on early prostate cancer detection, ...

Decipher Prostate Metastatic Genomic Classifier is now available for patients with metastatic prostate cancer.

Tad Eastman, a 60-year-old artist battling stage four prostate cancer, is showcasing his life's work in a York gallery. When you visit an art gallery, you'd expect for each piece of art each to tell a ...

Prostate cancer is the second-leading cause of cancer deaths among men in the United States and the rate of men diagnosed with advanced disease has been growing in recent years. 1 Veracyte estimates ...

Prostate cancer has distinct genetic properties in different groups of men that could be targeted to improve patient outcomes, new research suggests.

A Huntsville man is on a mission to help cut the out-of-pocket costs for preventative prostate cancer screenings. He's ...

A Texas man with terminal prostate cancer is spending the remainder of his time helping others all over the country ...

Dwyane Wade is opening up about one of the most vulnerable moments of his life — just before going under the knife for cancer ...

In Anchorage, Providence Alaska Medical Center has become the first facility in the state to offer an innovative treatment for metastatic prostate cancer. In March, the hospital began administering ...